Cortellis Deals Intelligence

Customer training and industry webinars

Cortellis Deals Intelligence provides comprehensive biopharma deals information, helping you search for potential partners, conduct due diligence, assess deal value, and explore deal structures and terms. From broad market wide trends to tightly focused comparables, Cortellis helps you make better decisions faster and negotiate the best deal.

Upcoming training

 

What’s new in Cortellis (20 mins + 10 mins optional Q&A)

 

Whether you use Cortellis for competitive or clinical trials data, deals information or regulatory documents, you’ll benefit from this short “What’s new in Cortellis” webinar. In 20 minutes you’ll understand how the recent Cortellis enhancements will upgrade your Cortellis experience.

After this session, you’ll be able to:

  • Recognize drug attrition risks for companies and diseases [see below image].
  • Increase success rates for your trials by customizing timeline data (i.e. enrollment end date and endpoint completion date) to help you find the right time to run your trials and maximize patient availability.
  • Quickly and easily pinpoint regulatory medical device documents by topic [i.e. clinical trial, PV advertising] and by medical device specialty [i.e. CV, hematology, orthopedic] with brand new indexing terms.
  • Learn about similar deals so you can find the best comparable alliances and maximize the value of your asset.

We will also share some future enhancements to be released in 2018.

Join us online to learn more about these recent and future Cortellis enhancements in 20 mins + 10 mins optional Q&A:

Tuesday, 18 September
12pm New York / 5pm London
Register
Wednesday, 19 September
9am London / 10am Paris
Register
Thursday, 20 September
9am New York / 2pm London
Register

 

Upcoming training

 

Cortellis Deals Intelligence – Essentials (30 mins + optional Q&A)

 

This introductory session will give you an overview of Cortellis Deals Intelligence and show you how it can answer questions such as:

  • What deal comparables are in my therapeutic area in recent years?
  • How would the deal value change if my asset was licensed in a different phase of development?
  • What deals has a potential partner done in the past? What were the terms of those deals?

The presenter will also be available to answer questions from the attendees.

 

Tuesday, September 11
9am San Francisco / 11am Chicago / 12pm New York
Register
Monday, October 1
9:30am New York / 2:30pm London / 3:30pm Paris
Register
Tuesday, October 9
9am San Francisco / 11am Chicago / 12pm New York
Register